Zhang, C., Smalley, I., Emmons, M. F., Sharma, R., Izumi, V., Messina, J., . . . Smalley, K. S. M. (2020). Non-canonical EphA2 signaling is a driver of tumor-endothelial cell interactions and metastatic dissemination in BRAF inhibitor resistant melanoma. J Invest Dermatol.
Chicago Style CitationZhang, Chao, et al. "Non-canonical EphA2 Signaling Is a Driver of Tumor-endothelial Cell Interactions and Metastatic Dissemination in BRAF Inhibitor Resistant Melanoma." J Invest Dermatol 2020.
MLA CitationZhang, Chao, et al. "Non-canonical EphA2 Signaling Is a Driver of Tumor-endothelial Cell Interactions and Metastatic Dissemination in BRAF Inhibitor Resistant Melanoma." J Invest Dermatol 2020.
Warning: These citations may not always be 100% accurate.